The upcoming share reduction is what will easily get us out of trips imo and hopefully much higher!!
Just way too much going on not to get excited about it. I'm willing to stick with Tggi into mid 2018 because it won't happen overnight. I am very confident everything will fall into place in time!!
TGGI Share Reduction
Trans Global Group Inc. (OTCMKTS:TGGI) received a boost in August after the company initiated an extended restructuring phase intended to reduce the total number of authorized shares. The company has already reduced its authorized shares by over 2.7 billion and reduced its float by 300 million common shares.
Plans are underway for the company’s CEO to return 530 million free trading common shares over the next few weeks. The share reduction spree has strengthened investor’s sentiments on the stock, given that it goes a long way in reducing dilution on the stock.
“TGGI has already developed detailed plans for further reductions in the Float totaling 3 billion shares, and possibly more, once all the corporate actions for its Cannabis Consortium subsidiary have been completed,” Trans-Global In a statement.
IPO Plans
In addition to share reductions, Trans Global Group Inc. (OTCMKTS:TGGI) wholly-owned subsidiary, Cannabis Consortium, is in the process of a Reg A filling. A successful application will allow the company to start accessing the capital markets as a separate trading entity.
The subsidiary is also planning to file form 15c-211 which, if approved, will allow it to trade independently under its own name and ticker. TGGI shareholders will remain the majority shareholders after Cannabis Consortium becomes a public company. Shareholders will be allowed to exchange a portion of their Trans Global Group Inc. (OTCMKTS:TGGI) shares for Cannabis Consortium shares as a way of expanding their holding base.
Cannabis Consortium plans to apply for Marijuana Licenses in several states across the United States. The licenses will allow the company to offer a wide range of products targeting both medical and recreational cannabis market. The company also plans to form joint ventures in some States as a way of expanding its footprint.
Cannabis Consortium is targeting four revenue streams comprised of specialty items, foodstuff, beverages, and its research division as it moves to pursue growth opportunities in the marijuana business. The research division will mostly focus on the medical benefits of CBD oil for the treatment of animals.
